IL271660B - Synthesis of the Lichondrins - Google Patents

Synthesis of the Lichondrins

Info

Publication number
IL271660B
IL271660B IL271660A IL27166019A IL271660B IL 271660 B IL271660 B IL 271660B IL 271660 A IL271660 A IL 271660A IL 27166019 A IL27166019 A IL 27166019A IL 271660 B IL271660 B IL 271660B
Authority
IL
Israel
Prior art keywords
optionally substituted
compound
optionally
salt
hydrogen
Prior art date
Application number
IL271660A
Other languages
English (en)
Hebrew (he)
Other versions
IL271660A (en
Original Assignee
Harvard College
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Eisai R&D Man Co Ltd filed Critical Harvard College
Publication of IL271660A publication Critical patent/IL271660A/en
Publication of IL271660B publication Critical patent/IL271660B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL271660A 2017-07-06 2018-07-06 Synthesis of the Lichondrins IL271660B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762529333P 2017-07-06 2017-07-06
US201762529310P 2017-07-06 2017-07-06
PCT/US2018/041005 WO2019010363A1 (en) 2017-07-06 2018-07-06 HALICHONDRINES SYNTHESIS

Publications (2)

Publication Number Publication Date
IL271660A IL271660A (en) 2020-02-27
IL271660B true IL271660B (en) 2022-09-01

Family

ID=63036376

Family Applications (3)

Application Number Title Priority Date Filing Date
IL271660A IL271660B (en) 2017-07-06 2018-07-06 Synthesis of the Lichondrins
IL307273A IL307273B2 (en) 2017-07-06 2018-07-06 Synthesis of halichondrins
IL295588A IL295588B2 (en) 2017-07-06 2018-07-06 Synthesis of halichondrins

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL307273A IL307273B2 (en) 2017-07-06 2018-07-06 Synthesis of halichondrins
IL295588A IL295588B2 (en) 2017-07-06 2018-07-06 Synthesis of halichondrins

Country Status (14)

Country Link
US (2) US11548898B2 (https=)
EP (2) EP4169924A3 (https=)
JP (2) JP7370313B2 (https=)
KR (2) KR102438417B1 (https=)
CN (2) CN118515685A (https=)
AU (2) AU2018297305B2 (https=)
BR (1) BR112020000141A2 (https=)
CA (2) CA3211559A1 (https=)
ES (1) ES2940688T3 (https=)
HU (1) HUE061306T2 (https=)
IL (3) IL271660B (https=)
MX (1) MX2020000142A (https=)
SG (1) SG11201912342QA (https=)
WO (1) WO2019010363A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SMT202200455T1 (it) 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019099646A1 (en) * 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof
CN111484393A (zh) * 2019-01-28 2020-08-04 上海茂晟康慧科技有限公司 一种顺,顺-3,5-二甲基-1-环己醇的制备方法
CN117820275A (zh) * 2023-12-29 2024-04-05 上海科技大学 一种列净类药物及其中间体的催化合成方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191687A (ja) 1985-02-20 1986-08-26 Fujisawa Pharmaceut Co Ltd ハリコンドリンb
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
JP2818381B2 (ja) 1994-01-18 1998-10-30 帝人株式会社 7−チアプロスタグランジン類およびその製造法
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
JP4454151B2 (ja) 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
JP2001305734A (ja) 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
SI2522663T1 (sl) 2004-06-03 2015-08-31 Eisai R&D Management Co., Ltd. Vmesne spojine za pripravo halihondrina B
US20060154312A1 (en) 2004-12-09 2006-07-13 Sergei Agoulnik Tubulin isotype screening in cancer therapy using halichondrin B analogs
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CN101657990B (zh) 2007-03-07 2014-03-19 交互数字技术公司 用于产生和处理MAC-ehs协议数据单元的方法和设备
US20100254996A1 (en) 2007-06-18 2010-10-07 Medimmune, Llc Synergistic treatment of cells that express epha2 and erbb2
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
CA2720632C (en) 2008-04-04 2016-12-20 Eisai R&D Management Co., Ltd. Halichondrin b analogs
RU2579511C2 (ru) 2010-01-26 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные фуро[3,2-в]пирана, применимые в синтезе аналогов
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2015501818A (ja) 2011-12-16 2015-01-19 アルフォラ リサーチ インコーポレイテッドAlphora Research Inc. 3−((2s,5s)−4−メチレン−5−(3−オキソプロピル)テトラヒドロフラン−2−イル)プロパノール誘導体およびそれらの有用な中間体を調製する方法
CA2860446C (en) 2011-12-29 2017-01-10 Alphora Research Inc. 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
CA2909209A1 (en) 2013-05-15 2014-11-20 Alphora Research Inc. 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
EP3016957A4 (en) 2013-07-03 2016-11-30 Alphora Res Inc SYNTHETIC METHOD FOR THE PRODUCTION OF CYCLIC C1-KETO ANALOGUE OF HALICHONDRIN B AND USEFUL INTERMEDIATE PRODUCTS, INCLUDING INTERMEDIATE PRODUCTS WITH -SO2- (P-TOLYL) GROUPS
BR112016009452B1 (pt) 2013-11-04 2022-06-07 Eisai R&D Management Co., Ltd Métodos de preparar intermediários na síntese de eribulina, métodos de preparar eribulina e mesilato de eribulina, e compostos intermediários
EP3077399B1 (en) 2013-12-06 2019-02-20 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
PE20231050A1 (es) 2016-03-02 2023-07-11 Eisai Randd Man Co Ltd Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
EP3582804A1 (en) 2017-02-20 2019-12-25 Polyphor Ag Pharmaceutical combinations for treating cancer
SMT202200455T1 (it) * 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS
WO2019009956A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College SUMMARY OF MEDIUM MEDIATED KETONE
WO2019099646A1 (en) 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AKIHIKO YAMAMOTO ET AL,, TOTAL SYNTHESIS OF HALICHONDRIN C, 18 January 2012 (2012-01-18) *
ATSUSHI UEDA ET AL,, TOTAL SYNTHESIS OF HALICHONDRIN A, THE MISSING MEMBER IN THE HALICHONDRIN CLASS OF NATURAL PRODUCTS, 2 April 2014 (2014-04-02) *
K.L. JACKSON ET AL,, A TOTAL SYNTHESIS OF NORHALICHONDRIN B, 11 February 2009 (2009-02-11) *

Also Published As

Publication number Publication date
EP3649135B1 (en) 2022-12-28
KR102438417B1 (ko) 2022-09-01
BR112020000141A2 (pt) 2020-07-14
KR20220124279A (ko) 2022-09-13
JP7370313B2 (ja) 2023-10-27
CN111433211B (zh) 2024-05-07
CA3211559A1 (en) 2019-01-10
CA3069160A1 (en) 2019-01-10
HUE061306T2 (hu) 2023-06-28
US20230128195A1 (en) 2023-04-27
US20210230177A1 (en) 2021-07-29
CN111433211A (zh) 2020-07-17
IL307273B2 (en) 2025-03-01
ES2940688T3 (es) 2023-05-10
IL271660A (en) 2020-02-27
EP4169924A2 (en) 2023-04-26
IL295588B1 (en) 2023-11-01
AU2018297305B2 (en) 2023-02-16
JP2023166381A (ja) 2023-11-21
WO2019010363A1 (en) 2019-01-10
AU2018297305A1 (en) 2020-01-16
CN118515685A (zh) 2024-08-20
US11548898B2 (en) 2023-01-10
MX2020000142A (es) 2020-07-22
SG11201912342QA (en) 2020-01-30
IL307273A (en) 2023-11-01
RU2020104842A (ru) 2021-08-06
WO2019010363A8 (en) 2019-06-06
AU2023203013A1 (en) 2023-06-01
CA3069160C (en) 2023-10-17
IL295588B2 (en) 2024-03-01
KR20200042464A (ko) 2020-04-23
IL307273B1 (en) 2024-11-01
IL295588A (en) 2022-10-01
JP7764432B2 (ja) 2025-11-05
JP2020536046A (ja) 2020-12-10
AU2023203013B2 (en) 2025-06-05
EP4169924A3 (en) 2023-07-05
EP3649135A1 (en) 2020-05-13

Similar Documents

Publication Publication Date Title
IL271660B (en) Synthesis of the Lichondrins
JP2020536046A5 (https=)
JP5866829B2 (ja) イオン液体
JP7663497B2 (ja) メチレンジスルホネート化合物の製造方法
CN111902396B (zh) 氨基磺酸锂的制造方法和新型氨基磺酸锂
JP2012528811A5 (https=)
UA125630C2 (uk) Спосіб одержання метоксиметилпіридиндикарбоксилату
CN107216307A (zh) 一种高效合成1,1‑二芳基烷烃类化合物的方法
KR20090080038A (ko) 몬테루카스트의 제조방법 및 그의 중간체
CN104326891A (zh) 3-三氟甲基吡唑中间体的制备方法
JP6146214B2 (ja) ベンゾビスチアゾール化合物
Zhu et al. PPh 3-mediated intramolecular conjugation of alkyl halides with electron-deficient olefins: facile synthesis of chromans and relevant analogues
CN107337691B (zh) 一种新型含磷阻燃剂及其制备方法
JP2016084348A (ja) ジフルオロアルキルベンゼン誘導体およびその製造方法
JP2014009330A5 (https=)
KR20190025626A (ko) 할로겐화 피리딘 유도체의 제조 방법
KR100746342B1 (ko) 구리 촉매 존재하에서 n―설포닐아미드 화합물의 제조방법
CN104860908B (zh) 一种合成bnc105的方法
CN104650143A (zh) 制备福沙匹坦二甲葡胺中间体的方法
KR102758936B1 (ko) 탄화수소고리 화합물의 제조방법
JP2024089686A (ja) 有機マンガン・ニッケル化合物、及び有機マンガン・ニッケル化合物の製造方法
EP3159330A1 (en) Sulfonate-based compound and method for preparing same
KR101365678B1 (ko) 페길화된 미코페놀산 유도체 및 그의 제조방법
CN103483337B (zh) 氟代异喹啉[a]吡咯类化合物及其制备方法
JP2018531907A5 (https=)